恒瑞医药(01276)拟回购10亿-20亿元A股股份

Core Viewpoint - Heng Rui Medicine (01276) announced a share buyback plan to enhance employee motivation and protect investor interests, reflecting confidence in the company's future development prospects [1] Group 1: Buyback Plan Details - The company plans to use its own funds to repurchase A-shares, with a total amount not less than RMB 1 billion and not exceeding RMB 2 billion [1] - The maximum repurchase price is set at RMB 90.85 per share [1] - The repurchased shares will be used for the A-share employee stock ownership plan [1]